Items tagged with Advocacy

It’s Time to End Drug-Resistant Tuberculosis: The Case for Action (post with simple image)

The cost of complacency: Economist Intelligence Unit report underscores major gaps in world’s response to drug-resistant TB.

Research, regulatory, and access considerations regarding pretomanid (post with simple image)

TB CAB releases document outlining key considerations regarding pretomanid in anticipation of FDA public advisory committee meeting on the TB Alliance's new drug application for pretomanid.

Community capacity building modules to accelerate DR-TB response (post with simple image)

Community capacity building modules to accelerate the response to drug-resistant TB launched at WHO meeting of national TB program managers and partners in the South-East Asia region.

Declaration of the Rights of People Affected by TB launched (post with simple image)

The launch of the Declaration is a significant step in recognizing the urgent need to adopt a human rights-based approach to TB and fund human rights-based interventions that overcome barriers to universal access.

Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB (post with simple image)

Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.

FDA Antimicrobial Drugs Advisory Committee recommends approval of pretomanid (post with simple image)

Investigational drug pretomanid is under regulatory review by FDA for treatment of XDR-TB and treatment-intolerant or non-responsive MDR-TB as part of a new investigational regimen.

Advocates call on TB Alliance to make public the pretomanid licensing agreement with Mylan (post with simple image)

Advocates request full access to the terms of the agreement granting Mylan the rights to commercialize pretomanid.

Activists demand Johnson & Johnson drop the price of bedaquiline (post with simple image)

Activists storm the corporate stall of Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) at the 9th South African AIDS Conference.

MSF technical brief: A rapid TB test for people living with HIV (post with simple image)

TB LAM can help close the deadly TB testing gap.

Online consultation to update the Global Plan to End TB (post with simple image)

Stop TB Partnership launches online consultation to update the Global Plan to End TB 2016-2020; Deadline for submission: 19 July 2019

Page 77 of 79 · Total posts: 0

←First 76 77 78 Last→